The Cancer Research Center of the Albert Einstein College of Medicine was established in 1972, when it involved 23 investigators. The Center now comprises 64 investigators in 8 basic science and 7 clinical departments. They are funded for their research activities at a current annual total (direct costs only) of $20,696,759, exclusive of the Cancer Center Grant itself. The research programs of the Center fall into 8 major areas: Immunooncology, Viral Oncology, Gene Expression, Receptor-Mediated Growth and Differentiation, Growth Control in Malignant Cells, Membrane Synthesis and Structure, Carcinogenic and Therapeutic Agents, and Clinical Oncology. Of the 64 cancer investigators, 25 are housed in the Chanin Cancer Research Institute. That building also houses a number of Shared Services and Facilities including an Analytical Ultrastructure Center, Barrier Mouse Facility, Fluorescent Activated Cell Sorter, and facilities for Biohazard Research, Nucleic Acid Synthesis, Hybridoma Production and Cell Culture, and Transgenic Mice and Stem Cells. A laboratory for Macromolecular Analysis and a Nuclear Magnetic Resonance Facility are housed in adjoining buildings. The budget of the Cancer Center Grant as of June 1, 1990, the last year of the present grant, will be $1,925,420. It provides salary support for 24 cancer investigators including Senior Leadership Personnel, Major Program Directors, and the Directors of Shared Facilities; seed support for incoming new investigators who have not yet obtained personal research grants; interim support for investigators who are reapplying for grant support; and partial funding for 13 shared facilities and services, shared items of equipment, an expanding Clinical Research Program, and administration. This application is a request for the renewal of this Cancer Center Support Grant for an additional 5-year period, at the level of $2,721,560 in the first year.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013330-21
Application #
3101328
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1977-06-01
Project End
1996-05-31
Budget Start
1992-06-01
Budget End
1993-05-31
Support Year
21
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Ruiz, Penelope D; Gamble, Matthew J (2018) MacroH2A1 chromatin specification requires its docking domain and acetylation of H2B lysine 20. Nat Commun 9:5143
Rohan, Thomas; Ye, Kenny; Wang, Yihong et al. (2018) MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer. PLoS One 13:e0191814
Walters, Ryan O; Arias, Esperanza; Diaz, Antonio et al. (2018) Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans. Cell Rep 25:663-676.e6
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Frimer, Marina; Miller, Eirwen M; Shankar, Viswanathan et al. (2018) Adjuvant Pelvic Radiation ""Sandwiched"" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial. Int J Gynecol Cancer 28:1781-1788
Kale, Abhijit; Ji, Zhejun; Kiparaki, Marianthi et al. (2018) Ribosomal Protein S12e Has a Distinct Function in Cell Competition. Dev Cell 44:42-55.e4
Lee, Chang-Hyun; Kiparaki, Marianthi; Blanco, Jorge et al. (2018) A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition. Dev Cell 46:456-469.e4
Mao, Serena P H; Park, Minji; Cabrera, Ramon M et al. (2018) Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res 20:131
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150

Showing the most recent 10 out of 1508 publications